Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 28, 2026
TickeronGET DAILY SIGNALS
ARRY's -64% YTD Slide and SEER's Cash Cushion: Contrasting Two Market Outliers

ARRY's -64% YTD Slide and SEER's Cash Cushion: Contrasting Two Market Outliers

Key Takeaways

  • ARRY is a solar tracking systems manufacturer with a record orderbook but sharply negative recent price momentum, while SEER is an early-stage proteomics (large-scale protein analysis) company trading near its 52-week low.
  • Both stocks are unprofitable on a net-income basis, but their profiles diverge sharply: ARRY generates roughly $1.2 billion in trailing revenue versus SEER's approximate $14 million.
  • ARRY carries a broad "Buy" analyst consensus and triple-digit average upside to price targets, whereas SEER faces an activist takeover campaign and a CFO transition.
  • SEER's roughly $220 million cash position provides a substantial runway relative to its small market capitalization, a key stability factor ARRY lacks at similar scale.
  • Risk profiles differ by sector: ARRY is exposed to utility-scale solar demand and policy, while SEER is exposed to academic funding cycles and competitive pressure in life-sciences tools.
  • For more context on each name, explore ARRY Major News and ARRY Today's Price Move, as well as SEER Major News and SEER Today's Price Move.
  • To see how AI-powered systems are currently positioning across the market, visit the Trending AI Robots page.

Setting the Scene

Array Technologies and Seer, Inc. sit in very different corners of the market, yet both highlight how sharply sentiment can pull away from underlying fundamentals. ARRY supplies solar tracking equipment at scale to utility developers, while SEER is an early-stage life-sciences firm bringing proteomics instruments to researchers. The comparison offers a useful lens for anyone weighing cyclical industrials recovery against a cash-heavy but pre-profit platform, especially when demand drivers and risk factors differ so markedly.

ARRY's Operational Strength Amid Price Pressure

Array Technologies builds single- and dual-axis solar trackers and supporting software that keep panels aligned with the sun for utility and distributed projects worldwide. The stock has recently traded in the low single digits after a roughly 64% year-to-date decline, well below its 52-week range. That weakness stands in contrast to a record orderbook near $2.5 billion and a book-to-bill ratio around 2x, which points to solid demand visibility ahead.

Analyst views have been mixed. Upgrades to Outperform from firms such as Mizuho highlight an attractive risk/reward and a potential 2027 rebound, while some price targets have been trimmed on worries about slowing demand and cash requirements. Strong adjusted EBITDA beats have appeared in recent quarters, yet revenue guidance has occasionally missed, leaving the market cautious. With a forward price-to-earnings ratio near 4.4 and a consensus "Buy" rating, ARRY shows a clear valuation-versus-momentum tension. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

SEER's Cash Position and Governance Developments

Seer, Inc. offers the Proteograph Product Suite, a platform for deep, unbiased proteomics used by researchers and biobanks. SEER trades near $2, close to its 52-week low, with a market capitalization of roughly $108 million. It holds about $220 million in cash and investments, so its cash position actually exceeds its market value—an uncommon buffer for a pre-profit company.

Recent developments include surpassing 100 peer-reviewed customer publications and progress on studies such as PRECISE-SG100K, alongside the departure of its CFO. Activist shareholders have put forward a non-binding acquisition proposal at $2.40 per share and started a proxy campaign, adding event-driven uncertainty. Revenue remains modest and has declined year-over-year in a soft academic funding environment and amid competitive pressure, though full-year guidance stands unchanged.

Side-by-Side Assessment

The clearest difference lies in scale and maturity. ARRY is an established manufacturer with substantial revenue, a sizable orderbook, and a visible route to profitability, yet its shares have faced sustained selling pressure linked to demand-cycle concerns. SEER is a small-cap innovator whose revenue base is minimal and shrinking, but its cash balance and takeover interest offer downside support and possible catalysts.

Growth drivers also point in different directions. ARRY depends on utility-scale solar buildouts, domestic manufacturing incentives, and international expansion, leaving it sensitive to energy policy and financing conditions. SEER relies on adoption of still-emerging technology by academic, biopharma, and biobank customers, making it sensitive to research funding and competition. Momentum has been weak for both, though ARRY enjoys broader analyst support while SEER carries event risk from its activist campaign and leadership changes. These trade-offs suit very different investor profiles.

AI Perspective on Relative Positioning

From what I see in the data, Tickeron's AI would likely favor ARRY at present. The firm shows a record orderbook, favorable analyst consensus, and a depressed valuation relative to projected earnings, suggesting negative sentiment may already be priced in. In contrast, SEER pairs strong cash stability with lower earnings visibility, ongoing revenue declines, and governance uncertainty, which tends to reduce trend consistency. This remains a probabilistic view of relative positioning rather than a firm forecast, and both names carry distinct risks that could alter the picture as fresh information arrives.

Using AI Tools for Deeper Analysis

One resource I turn to when comparing names like these is Tickeron’s AI Trading Bots. The platform offers a wide selection of automated strategies across thousands of tickers, with different styles, timeframes, and risk levels. Reviewing the trending systems helps put current positioning into context and shows how data-driven approaches are handling similar situations right now. AI Trading Bots

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARRY, SEER

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ARRY's RSI Indicator leaves overbought zone

The 10-day RSI Indicator for ARRY moved out of overbought territory on November 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 instances where the indicator moved out of the overbought zone. In 20 of the 21 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARRY as a result. In 78 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for ARRY turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 38 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

ARRY moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

ARRY broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARRY entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for ARRY crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Following a +40.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARRY advanced for three days, in 191 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.462) is normal, around the industry mean (2.537). P/E Ratio (-6.099) is within average values for comparable stocks, (6.086). Projected Growth (PEG Ratio) (0.399) is also within normal values, averaging (1.699). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.543) is also within normal values, averaging (5.133).

The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ARRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

Notable companies

The most notable companies in this group are First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SolarEdge Technologies (NASDAQ:SEDG), Canadian Solar (NASDAQ:CSIQ).

Industry description

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

Market Cap

The average market capitalization across the Alternative Power Generation Industry is 6.02B. The market cap for tickers in the group ranges from 3.39K to 270.64B. CDVM holds the highest valuation in this group at 270.64B. The lowest valued company is MAXNQ at 3.39K.

High and low price notable news

The average weekly price growth across all stocks in the Alternative Power Generation Industry was -24%. For the same Industry, the average monthly price growth was -28%, and the average quarterly price growth was -58%. ZEO experienced the highest price growth at -1%, while SPWR experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Alternative Power Generation Industry was 97%. For the same stocks of the Industry, the average monthly volume growth was 131% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 44
Price Growth Rating: 76
SMR Rating: 79
Profit Risk Rating: 99
Seasonality Score: -14 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical drugs

Industry AlternativePowerGeneration

Industry
Biotechnology
Address
3901 Midway Place NE
Phone
+1 505 881-7567
Employees
1200
Web
https://www.arraytechinc.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.